MCH ADVISORY EQUITY RESEARCH
Institutional research — not investment advice ← Library
BG HOLD REF $107 PW TARGET $115 +7% Single-name research · 1 July 2026
Equity ResearchConsumer Staples · Agricultural Products & Services
BG

Bunge Global SA (BG)

The bull case — 'Spike — Supply Dislocation' (8% weight) — targets $233, +118% vs spot. It needs Gross Margin to surprise to the upside.

Verdict
HOLD
Triangulated fair value $115
Reference
$107
Close · 1 July 2026
PW Target
$115 +7%
Probability-weighted
Horizon
12 mo
MCH Advisory
$115
Fair value
$115
Scenario PWEV
13.9x
Forward P/E
$21B
Market cap
$70 – $135
52-week range
Contents

Rating: HOLD

Metric Value
Current Price $107
Triangulated Fair Value $115
12-mo Scenario PWEV $115
Implied Return +8%
Forward P/E 13.9x
Market Cap $21B
52-Week Range $70 – $135

Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.

Investment Thesis

The bull case — 'Spike — Supply Dislocation' (8% weight) — targets $233, +118% vs spot. It needs Gross Margin to surprise to the upside.

The dashboard below is the whole argument on one page: spot ($107) against each valuation anchor, the scenario tree, technicals and the options-implied move.

Integrated dashboard. The five valuation anchors bracket the <img src=
Integrated dashboard. The five valuation anchors bracket the $107 spot from $15 to $132 — stretched — spot sits above the skeptical blend.

Anti-Thesis (The Real Bear Case)

The structural case — 'Structural — Crush / Protein Margin Reset' (22%) — targets $40, -62% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.

Key Debate

Gross Margin explains 65% of Monte Carlo outcome variance — the single variable that decides which side is right.

Earnings-Call Disconfirmation & Sentiment

Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.

Management vs analyst tone (2026Q1): management +0.23 vs analyst floor +0.08 → delta +0.15 (n=23 mgmt / 14 Q&A; 6th pctile across the S&P book, z -1.5).

Flag: CANDID — management unusually candid/cautious vs peers (relatively low spin).

Quarter Mgmt Analyst Delta
2026Q1 +0.23 +0.08 +0.15
2025Q4 +0.45 +0.26 +0.20
2025Q3 +0.48 +0.21 +0.27
2025Q2 +0.53 +0.21 +0.32

News (last 365d, 1000 articles): avg ticker sentiment +0.19 (bullish 27% / bearish 4%)

Scenario Analysis

The tree runs from a structural 'Structural — Crush / Protein Margin Reset' downside ($40) to a 'Spike — Supply Dislocation' bull case ($233); the probability-weighted blend (PWEV $115) is +8% versus spot.

Scenario Probability Target Return
Structural — Crush / Protein Margin Reset 22% $40 -62%
Cyclical Margin Trough 18% $72 -33%
Base — Mid-Cycle Crush / Protein Margins 32% $117 +10%
Upcycle — Tight Margins 20% $186 +75%
Spike — Supply Dislocation 8% $233 +118%
Probability-Weighted (PWEV) $115 +8%

Scenario rationale — what each probability buys (the driver path behind every target):

  • Structural — Crush / Protein Margin Reset (22%, $40). Structural impairment — crush / protein margin reset: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 40.44; probability: 0.22.
  • Cyclical Margin Trough (18%, $72). Cyclical downturn — ag-processing crush margins / protein cycle + commodity & feed costs weakens for 1–2 years before normalising. Drivers — implied_target: 72.0; probability: 0.18.
  • Base — Mid-Cycle Crush / Protein Margins (32%, $117). Mid-cycle — normalised ag-processing crush margins / protein cycle + commodity & feed costs; disciplined capital allocation; steady returns. Drivers — implied_target: 116.88; probability: 0.32.
  • Upcycle — Tight Margins (20%, $186). Upside — tight crush / protein margins lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 186.43; probability: 0.2.
  • Spike — Supply Dislocation (8%, $233). Upside tail — sustained tight conditions or a structural re-rate on tight crush / protein margins. Drivers — implied_target: 233.18; probability: 0.08.
Five-scenario tree. Probability-weighted targets around the <img src=
Five-scenario tree. Probability-weighted targets around the $107 spot; PWEV $115 (+8%). the payoff is skewed to the upside — upside to $233 against downside to $40

Valuation Triangulation

Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.

Method Basis Fair Value vs Spot
Monte Carlo median (Student-t + regime) multiple $103 -3%
Peer P/E re-rate multiple $132 +24%
Peer EV/Revenue re-rate multiple $351 +229%
Scenario PWEV multiple $115 +8%
DCF (5-year + terminal) cash flow + terminal × $15 -86%
Triangulated (weighted) $115 +8%

DCF excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.

Monte Carlo — the distribution, not a point

10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $103 and 48% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (65% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.

Monte Carlo distribution. Median <img src=
Monte Carlo distribution. Median $103; P(price > current) 48%. P10–P90: $33–$235.

DCF — the cash-flow anchor

Independent of the market multiple: a 5-year path, WACC 9.0%, 13x terminal FCF multiple → $15. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.

Independent DCF. WACC 9.0%, 13x terminal → <img src=
Independent DCF. WACC 9.0%, 13x terminal → $15.

Peer benchmarking — relative value

Against the peer cohort, re-rating to the peer-median forward multiple (P/E 17.235x) implies $132. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.

Cross-sectional peer benchmarking. Peer-median fwd P/E 17.235x → <img src=
Cross-sectional peer benchmarking. Peer-median fwd P/E 17.235x → $132; EV/Rev re-rate → $351.

Across all anchors the spread is wide (genuine disagreement — low valuation confidence).

Revenue-Segment Breakdown

The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)

Segment Revenue Mix Growth Op margin Multiple Capex % Tag
Agricultural Products & Protein $80.5B 100% 2% 0% 15x 6% ESTIMATE

Named Exposures

Demand & pricing cycle (FACT/ESTIMATE)

Dimension Assessment
driver ag-processing crush margins / protein cycle + commodity & feed costs
net_debt_or_cash_b -15.45

Capital intensity & shareholder returns (ESTIMATE)

Dimension Assessment
capex_pct_revenue 0.06
div_yield 0.0259

Structural risk vs optionality (INFERENCE)

Dimension Assessment
downside crush / protein margin reset
upside tight crush / protein margins

Industry Context — Consumer Staples — Ag

This name sits in the Consumer Staples — Ag as a ag_products. ag-processing crush margins / protein cycle + commodity & feed costs Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.

Value chain: ADM (ag_products) · BG (ag_products) · TSN (ag_products)

Shared state Capex path House view This name implies
Crush / Protein Margin Reset 40% 40%
Mid-Cycle — Normalised Margins 32% 32%
Tight-Margin Upcycle 28% 28%

On the cluster's key downside — Crush / Protein Margin Reset () — this name implies 40% vs the cluster house view of 40% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.

Structure: Shared State — The staples_ag cycle is the shared macro driver. Driver — ag-processing crush margins / protein cycle + commodity & feed costs Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).

Model Appendix

DCF — line items

Year Revenue Op income − Capex + D&A FCF PV(FCF)
FY+1 $82B $2B $5B $5B $1B $1B
FY+2 $84B $2B $5B $5B $1B $1B
FY+3 $85B $2B $5B $5B $1B $1B
FY+4 $85B $2B $5B $5B $1B $1B
FY+5 $86B $2B $5B $5B $1B $1B
Terminal $1B × 13x $13B

FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 6% of revenue, weighted from the segments) — not a single conversion fudge.

WACC 9.0% · Σ PV(FCF) $6B + PV(terminal) $13B = EV $18B; + net cash → equity $3B ÷ diluted shares 0.19B = $15/share (exit-multiple terminal).

  • Gordon (perpetuity-growth) terminal at 2.5% → $28/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
  • Incremental ROIC on the forecast capex ≈ 1% vs WACC 9% → below WACC — the incremental build is value-dilutive.

Peer set

Peer EV/Rev Fwd P/E Growth Op margin
ADM 0.582x 16.61x 2% 1%
TSN 0.501x 12.92x 2% 4%
DLTR 1.495x 17.86x 5% 9%
CHD 4.022x 26.04x 4% 20%
Median 1.0385x 17.235x

Peer-median fwd P/E → $132; EV/Rev → $351.

Weighted fair-value math

Anchor Value Weight Contribution
Scenario PWEV $115 50% $58
Monte Carlo median $103 30% $31
Peer P/E $132 20% $26
Triangulated 100% $115

Sensitivity

DCF/share — WACC × terminal multiple

WACC \ Term× 9.1x 11.0x 13.0x 14.9x 16.9x
7% $1 $12 $22 $33 $44
8% $-2 $8 $18 $28 $39
9% $-5 $5 $15 $24 $34
10% $-8 $1 $11 $20 $29
11% $-10 $-2 $7 $16 $25

DCF/share — revenue CAGR Δ × op-margin Δ

CAGRΔ \ MgnΔ -3.0pp -1.5pp +0.0pp +1.5pp +3.0pp
-3.0pp $-92 $-36 $20 $76 $132
-1.5pp $-102 $-42 $18 $77 $137
+0.0pp $-113 $-49 $15 $78 $142
+1.5pp $-125 $-57 $11 $79 $147
+3.0pp $-138 $-65 $7 $79 $152

Tornado — DCF/share swing by driver (widest first)

Driver Low High Swing
Op margin ±3pp $-113 $142 $255
Terminal × ±15% $5 $24 $19
Revenue CAGR ±3pp $20 $7 $13
WACC ±1pp $11 $18 $7
FCF conversion ±10% $15 $15 $0

Company lever — SoP/share vs Agricultural Products & Protein multiple (AI re-rating) (base 15x)

Multiple 10.5x 12.8x 15.0x 17.2x 19.5x
SoP/share $4,277 $5,232 $6,145 $7,057 $8,012

Load-Bearing Assumptions

DCF: WACC 9%, terminal multiple 13×, FY+5 revenue $86B. Triangulation leans 41% on DCF, 29% on PWEV.

Reasons the Thesis Could Fail (Falsifiable)

DCF $15 vs MC median $103 diverge by 86%. Investigate which assumptions differ. A miss on Gross Margin drops the case toward the structural target $40.

Fact / Inference / Speculation

  • FACT: Spot $107; 52-week range $70–$135; engine rating HOLD; base-case target $115 (+8%).
  • INFERENCE: Triangulated FV $115 (+8%). Gross Margin explains 65% of Monte Carlo outcome variance — the single variable that decides which side is right.
  • SPECULATION: At current prices the embedded bet is that Gross Margin surprises to the upside — Gross Margin carries 65% of outcome variance.

Recommendation: HOLD

Balanced: triangulated fair value $74 (-31% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin (65% of variance) — a fundamental call. SBC runs —M TTM (disclosed in the appendix).

Disclosures. This document is produced by MCH Advisory Services for informational and quantitative-research purposes only. It does not constitute investment, financial, legal or tax advice, nor an offer or solicitation to buy or sell any security. Price targets and probabilities are model outputs, not guarantees; past performance and backtested/simulated figures are not reliable indicators of future results. The author may hold positions in instruments mentioned and is not a registered financial adviser. Conduct your own due diligence and consult a qualified, registered adviser before making any investment decision.